These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 18393973)
1. Recurrent primary cutaneous lymphoma with florid pseudoepitheliomatous hyperplasia masquerading as squamous cell carcinoma. Biswas A; Gey van Pittius D; Stephens M; Smith AG Histopathology; 2008 May; 52(6):755-8. PubMed ID: 18393973 [No Abstract] [Full Text] [Related]
2. Primary Cutaneous Lymphoma-Associated Pseudoepitheliomatous Hyperplasia Masquerading as Squamous Cell Carcinoma in a Young Adult. Ansari M; Azmoodeh Ardalan F; Najafi M; Goodarzi A; Ghanadan A Acta Med Iran; 2015 Dec; 53(12):785-8. PubMed ID: 26749237 [TBL] [Abstract][Full Text] [Related]
3. Pseudoepitheliomatous hyperplasia: a review. Zayour M; Lazova R Am J Dermatopathol; 2011 Apr; 33(2):112-22; quiz 123-6. PubMed ID: 21399447 [TBL] [Abstract][Full Text] [Related]
4. Malignant lymphoma presenting as pseudoepitheliomatous hyperplasia. A report of two cases. Krasne DL; Warnke RA; Weiss LM Am J Surg Pathol; 1988 Nov; 12(11):835-42. PubMed ID: 3189693 [TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers. Barksdale SK; O'Connor N; Barnhill R Surg Oncol Clin N Am; 1997 Jul; 6(3):625-38. PubMed ID: 9210358 [TBL] [Abstract][Full Text] [Related]
12. Complete loss of epithelial antigens in a recurrent tumour from squamous cell carcinoma of the scalp. Tseng JT; Chen WY; Wang KH; Tsai TH J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1098-9. PubMed ID: 19175483 [No Abstract] [Full Text] [Related]
13. Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative. Kadin ME; Pinkus JL; Pinkus GS; Duran IH; Fuller CE; Onciu M; Kawaguchi H; Morris SW Am J Surg Pathol; 2008 Sep; 32(9):1421-6. PubMed ID: 18670345 [TBL] [Abstract][Full Text] [Related]
15. Sclerosing squamous cell carcinoma of the skin, an underemphasized locally aggressive variant: a 20-year experience. Salmon PJ; Hussain W; Geisse JK; Grekin RC; Mortimer NJ Dermatol Surg; 2011 May; 37(5):664-70. PubMed ID: 21269350 [TBL] [Abstract][Full Text] [Related]
16. [Changes in mitotic activity of cells of the epidermis in pseudoepitheliomatous hyperplasia and spinocellular cancer of the skin]. Berenbeĭn BA; Kazantseva IA Vestn Dermatol Venerol; 1973 Aug; 47(8):25-8. PubMed ID: 4767949 [No Abstract] [Full Text] [Related]
17. Issues with keratoacanthoma, pseudoepitheliomatous hyperplasia and squamous cell carcinoma within tattoos: a clinical point of view. Kluger N J Cutan Pathol; 2010 Jul; 37(7):812-3. PubMed ID: 19614733 [No Abstract] [Full Text] [Related]
18. Keratoacanthoma-type squamous cell carcinoma developing in a skin graft donor site after tumor extirpation at a distant site. May JT; Patil YJ Ear Nose Throat J; 2010 Apr; 89(4):E11-3. PubMed ID: 20397130 [TBL] [Abstract][Full Text] [Related]
19. Recurrent primary cutaneous large B-cell lymphoma after a long-term remission. Yamamoto Y; Nakamine H; Nakamura S Pathol Int; 2006 Oct; 56(10):645-7. PubMed ID: 16984625 [No Abstract] [Full Text] [Related]
20. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Leach BC; Kulbersh JS; Day TA; Cook J Dermatol Surg; 2008 Apr; 34(4):483-97. PubMed ID: 18248467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]